Abstract
Prostate cancer is the most frequently diagnosed cancer in the United States. Until recently most attempts by epidemiologists to identify risk factors and understand the etiology of prostate cancer were unfocused, searching for clues which could lead to more definitive and detailed evaluations. In the past few years epidemiologic studies have increasingly centered around three main themes — family history, diet, and hormones — although a few additional risk factors seem to be reproducible across studies and among different target populations, so that these also have received substantial recent attention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adlercreutz H, Markkanen H, Watanabe S (1993) Plasma concentrations of phytoestrogens in Japanese men. Lancet 342:1209–1210
American Cancer Society: Cancer Facts and Figures (1994)
Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15:617–631
Berg JW (1975) Can nutrition explain the pattern of international epidemiology of hormone-dependent cancers? Cancer Res 35:3345–3350
Cannon-Albright L, Eeles R (1995) Progress in prostate cancer. Nature Genet 9:336–338
Caporaso N, Goldstein A (1995) Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics 5:59–63
Carey AH, Waterworth D, Patel K et al. (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873–1876
Carter BS, Beaty TH, Steinberg GD et al. (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89:3367–3371
Carter BS, Bova S, Beaty TH et al. (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150:797–802
Coetzee GA, Ross RK (1994) Prostate cancer and the androgen receptor. J Natl Cancer Inst 86:872–873
Coffey DS (1979) Physiological control of prostatic growth. An overview. In: Prostate Cancer. UICC Technical Report Series, vol 48. International Union Against Cancer, Geneva
Coffey DS (1993) The molecular biology of the prostate. In: Lepor H, Lawson RK (eds) Prostate Disease. Saunders, Philadelphia, pp 28–56
Corder EH, Guess HA, Hulka BS et al. (1993) Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prey 2:467–472
Dupont A, Gomez JL, Cusan L, Koutsilieris, Labrie F (1993) Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy. J Urol 150:908–913
Eagle LR, Yin X, Brothman AR et al. (1995) Mutation of the MXI1 gene in prostate cancer. Nature Genet 9:249–255
Ellis L, Nyberg H (1992) Racial/ethnic variations in male testosterone levels: a probable contribution to group differences in health. Steroids 57:72–75
Gaddipati JP, McLeod DG, Heidenberg HB et al. (1994) Frequent detection of codon 877 mutation in the androgenreceptor gene in advanced prostate cancers. Cancer Res 54:2861–2864
Gann PH, Hennekens CH, Sacks FM et al. (1994) Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86:281–286
Giovannucci E, Rimm EB, Colditz GA et al. (1993) A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85:1571–1579
Harris SE, Rong Z, Harris MA, Lubahn DD (1990) Androgen receptor in human prostate carcinoma LNCaP/ADEP cells contains a mutation which alters the specificity of the steroid-dependent transcriptional activation region. Endocrinology 126 (Suppl):93
Hayes RB, Bogdanovicz FAT, Schroeder FH et al. (1988) Serum retinol and prostate cancer. Cancer 62:2021–2026
Hayes RB, Liff JM, Pottern LM et al. (1995) Prostate cancer risk in US Blacks and Whites with a family history of prostate cancer. Int J Cancer 60:361–364
Hill PB, Wynder EL (1979) Effect of vegetarian diet and dexamethasone on plasma prolactin, testosterone and dehydroepiandrosterone in men and women. Cancer Lett 7:273–282
Hirayama T (1979) Epidemiology of prostate cancer with special reference to the role of diet. NCI Monogr 53:149155
Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE (1988) Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer 57:326–331
Howie BJ, Schultz JD (1985) Dietary and hormonal interrelationships among vegetarian Seventh-Day Adventists and nonvegetarian men. Am J Clin Nutr 42:127–134
Hsing WA, Comstock GW, Abbey H et al. (1990) Serologic precursors of cancer, retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 82:941–946
Huber DR, Hong S, Ross JA (1986) The international experience with vasectomy. In: Zatuchni GI, Goldsmith A, Spieler JM (eds) Male contraception: advances and future prospects. Harper and Row, Philadelphia, pp 7–18
Irvine RA, Yu MC, Ross RK, Coetzee GA (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55:1937–1940
Isaacs WB, Bova GS, Morton RA et al. (1995) Molecular genetics and chromosomal alterations in prostate cancer. Cancer 75:2004–2012
John EM, Whittemore AJ, Wu AH et al. (1995) Vasectomy and prostate cancer: results from a multiethnic case-control study. J Natl Cancer Inst 87:662–669
Kark JD, Smith AH, Switzer BR et al. (1981) Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J Natl Cancer Inst 66:7–16
Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265:2037–2048
Lee W-H, Morton RA, Epstein JI et al. (1994) Cytidine methylation of regulatory sequences near the p-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91:11733–11737
LeMarchand L, Kolonel LN, Wilkens LR et al. (1994) Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5:276–282
Lookingbill DP, Demers LM, Wang C et al. (1991) Clinical and biological parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab 72:1242–1248
Monroe KR, Yu MC, Kolonel LN et al. (1995) Evidence of X-linked genetic component to prostate cancer risk. Nature Med 1:827–829
Morrison NA, Jian CQ, Tokita A et al. (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367:284–287
Muir C, Waterhouse J, Mack T et al. (eds) (1987) Cancer incidence in five continents, vol V. IARC, Lyons
Narod SA, Dupont A, Cusan L et al. (1995) The impact of family history on early detection of prostate cancer. Nature Med 1:99–101
Noble RL (1977) The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 37:1929–1933
Parker KL, Schimmer BP (1994) The role of nuclear receptors in steroid hormone production. Semin Cancer Biol 5:317–325
Reichman ME, Hayes RB, Ziegler RG et al. (1990) Serum vitamin A and subsequent development of prostate cancer in the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cancer Res 50:2311–2315
Ries LAG, Hankey BD, Edwards BK (eds) (1990) Cancer Statistics Review, 1973–87. NIH, Bethesda, MD. NIH Publ 90:2789
Ross RK, Schottenfeld D (1996) Prostate. In: Schottenfeld D, Fraumeni J (eds) Cancer epidemiology and prevention, 2nd edn. W.B. Saunders, Philadelphia (in press)
Ross RK, McCurtis JW, Henderson BE et al. (1979) Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer 39:284–292
Ross RK, Bernstein L, Judd H et al. (1986) Serum testosterone levels in young black and white men. J Natl Cancer Inst 76:45–48
Ross RK, Bernstein L, Lobo RA et al. (1992) 5-alpha-reductase activity and risk of prostate cancer among Japanese and U.S. white and black males. Lancet 339:887–890
Ross RK, Coetzee GA, Reichardt J, Skinner E, Henderson BE (1995) Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer 74:1778–1782
Sartor O, Cooper M, Weinberger M et al. (1994) Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of “hormone-refractory” prostate cancer. J Natl Cancer Inst 86:222–227
Scher HI, Kelly WK (1993) Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer. J Clin Oncol 11:1566–1572
Severson RK, Nomura AMY, Grove JS et al. (1989) A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49:1857–1860
Sharief Y, Wilson EM, Hall SH et al. (1995) Androgen receptor gene mutations associated with prostatic carcinoma. Proc AACR 36:269
Shimizu H, Ross RK, Bernstein L (1991) Possible underestimation of incidence rate of prostate cancer in Japan. Jpn J Cancer Res 82:483–485
Skowronski RJ, Peehl DM, Feldman D (1993) Vitamin D and prostate cancer: 1,25-dihydroxyvitamin D3 receptors and action in human prostate cancer cell lines. Endocrinology 132:1952–1960
Spruck CH, Ohneseit PF, Gonzalez-Zulueta M et al. (1994) Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784–788
Steinberg GD, Carter BS, Beaty TH et al. (1990) Family history and the risk of prostate cancer. Prostate 17:337–347
Suzuki H, Sato N, Watabe Y et al. (1993) Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 46:759–765
Taplin M-E, Bubley GJ, Shuster TD et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393–1398
Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW (1993) Tissue distribution and ontogeny of steroid 5a-reductase isoenzyme expression. J Clin Invest 92:903–910
Veldscholte J, Ris-Stalpers C, Kuiper GGJM et al. (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 173:534–540
Visakorpi T, Hyytinen E, Koivisto P et al. (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 9:401–406a
Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9:138–141
Willett WC, Polk BF, Underwood BA et al. (1984) Relation of serum vitamins A and E, and carotenoids to the risk of cancer. N Engl J Med 310:430–434
Yamagata Z, Miyamura T, Iijima S, Asaka A, Sasaki M, Kato J, Koizumi K (1994) Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women. Lancet 344:1027
Zaridze DG, Boyle P, Smans M (1984) International trends in prostatic cancer. Int J Cancer 33:223–230
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ross, R.K., Coetzee, G.A. (1996). The Epidemiology and Etiology of Prostate Cancer. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Prostate. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60956-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-60956-5_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64627-0
Online ISBN: 978-3-642-60956-5
eBook Packages: Springer Book Archive